2Testai FD, Gorelick PB. Inherited metabolic disorders and stroke part 1:Fabry disease and mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes[J]. Arch Neurol, 2010, 67:19-24. 被引量：1
3Linthorst GE, Poorthuis BJ. Enzyme activity for determination of presence of Fabry disease in women results in 40% false-negative results[J]. J Am Coll Cardiol, 2008, 51:2082. 被引量：1
4Lin HY, Chong KW, Hsu JH, et al. High incidence of the ardiac variant of fabry disease revealed by newborn screening in the Taiwan Chinese population[J]. Circulation, 2009, 2:450-456. 被引量：1
6Imbriaco M, Pisani A, Spinelli L, et al. Effects of enzyme-replacement therapy in patients with Anderson-Fabry disease:a prospective long-term cardiac magnetic resonance imaging study[J]. Heart, 2009, 95:1103-1107. 被引量：1
2Desnick R,Ioannou Y,Eng C,et al.Alpha-galactosidase a deficiency:fnhry disease//Scriver CR,Beaudet AL,Sly WS,et al.The metabolic and molecular bases of inherited disease.8th.New York:McGraw-Hill,2001:3733-3774. 被引量：1
3Gannan SC,Garboczi DN,et al.The molecular defect leading to Fabry disease:structure of human alpha-galectesidase.J Mol Biol,2004,337:319-335. 被引量：1
4Mehta A,Ricci R,Widmer U,et al.Fabry disease defined:baseline clinical manifestations of 366 patients in the Fabry outcome survey.Eur J Clin Invest,2004,34:236-242. 被引量：1
5Eng CM,Fletcher J,Wilcox WR,et al.Fabry disease:baseline medical characteristics of a cohort of 1765 males and females in the Fabry registry.J Inherit Metab Dis,2007,30:184-192. 被引量：1
6Orssaud C,Dufer J,Germain D.Ocular manifestations in Fabry disease:a survey of 32 hemizygous male patients.Ophthalmic Genet,2003,24:129-139. 被引量：1
8Kampmann C,Baehner F,Whybra C,et al.Cardiac manifestations of Anderson-Fabry disease in heterozygous females.J Am Coll Cardiol,2002,40:1668-1674. 被引量：1
9Wilcox WR,Ohveira JP,Hopkin RJ,et al.Females with Xlinked Fabry disease frequently have significant organ involvement.Mol Genet Metab,2008,93:112-128. 被引量：1
10Schiffmann R,Ries M,Timmous M,et al.Long-term therapy with agalsidase alfa for Fabry disease:safety and effects on renal function in a home infusion setting.Nephrol Dial Transplant,2006,21:345-354. 被引量：1
3Boiten J, Lodder J, Kessels F. Two clinically distinct lacunar infarct entities? A hypothesis[J]. Stroke, 1993, 24:652-656. 被引量：1
4O'Sullivan M, Lythgne D J, Pereira AC, et al. Patterns of cerebral blood flow reduction in patients with ischemic leukoaraiesis[J]. Neurology, 2002, 59:321- 326. 被引量：1
5Terborg C, Gora F, Weiller C, et al. Reduced vasomotor reactivity in cerebral microangiopathy:a study with near-infrared spectroscopy and transcranial Doppler sonography[J]. Stroke, 2000, 31:924-929. 被引量：1
7Vahedi K, Alamowitch S. Clinical spectrum of type IV collagen(COL4A1) mutations:a novel genetic multisystem disease[J]. Curr Opin Neurol, 2011 24:63-68. 被引量：1
8de Vries LS, Mancini GM. Intracerebra! hemorrhage and COL4A1 and COL4A2 mutations, from fetal life into adulthood[J]. Ann Neurol, 2012, 71:439-441. 被引量：1
9Lemmens R, Maugeri A, Niessen HW, et al. Novel COL4AI mutations cause cerebral small vessel disease by haploinsufficiency[J]. Hum Mol Genet 2013, 22:391-397. 被引量：1
